AFP dynamics, DCP/AFP-L3, PET avidity, and MVI-oriented radiomics help identify high-risk tumour biology within or beyond morphologic criteria and should guide the intensity of down-staging, observation periods, and exception requests. This evidence concerns the gene AFP and neoplasm.